Prostate News and Research

RSS

Prophylactic cranial irradiation used as standard approach for patients with NSCLC

Prophylactic cranial irradiation, a technique used to prevent the clinical development of brain metastases, is established as a standard approach for many patients with small cell lung cancer after initial therapy.

19 Mar 2019

Hormonal treatment associated with depression in men with prostate cancer

Men who receive anti-hormonal treatment after having their prostate removed are 80% more likely to suffer from depression than men who don't receive this treatment. This leads researchers to suggest that patients receiving androgen deprivation therapy should be monitored for post-surgical depression.

18 Mar 2019

Study highlights the need for psychiatric care to be integrated into cancer treatment

Patients with prostate, bladder or kidney cancers are at greater risk of dying if they have had psychiatric care prior to the cancer treatment. In addition, patients with these cancers show greater suicide risk than the general population, even once the data is corrected for previous psychiatric care.

18 Mar 2019

Compounds found in coffee may inhibit growth of prostate cancer

For the first time, scientists have identified compounds found in coffee which may inhibit the growth of prostate cancer. This is a pilot study, carried out on drug-resistant cancer cells in cell culture and in a mouse model; it has not yet been tested in humans.

18 Mar 2019

Testosterone treatment lowers recurrence rates in low-risk prostate cancer patients

In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients.

18 Mar 2019

Prostate cancer treatment breakthrough

Researchers have developed a method by which thousands of men with prostate cancer could choose their own treatment.

13 Mar 2019

New risk model can predict survival of non-metastatic prostate cancer patients

A new risk model, easily accessible on a web interface, can predict the survival of non-metastatic prostate cancer patients, as well as the effect of different treatment approaches on survival.

13 Mar 2019

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.

11 Mar 2019

Cancer patients with mental health history have greater risk of death

Cancer patients who have been hospitalized for mental health problems prior to their cancer diagnosis were 73% more likely to die from their cancer compared to those who had never had psychiatric help, according to new research published in the British Journal of Cancer.

7 Mar 2019

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

By loading a chelation drug into a nano-sized homing device, researchers at Clemson University have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer.

5 Mar 2019

Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma

Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines.

1 Mar 2019

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors.

26 Feb 2019

New protein 'switch' could stop progression of blood-poisoning and increase chances of survival

Scientists at the University of British Columbia have discovered a new protein "switch" that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.

26 Feb 2019

Lack of diversity in cell lines does not allow minorities to reap the benefits of precision medicine

As the biomedical field races to develop therapies based on an individual's genetic makeup, a City of Hope scientist and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.

25 Feb 2019

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts.

22 Feb 2019

New AI can identify, predict development of different combinations of cancer symptoms

Cancer patients who undergo chemotherapy could soon benefit from a new AI that is able to identify and predict the development of different combinations of symptoms - helping to alleviate much of the distress caused by their occurrence and severity.

20 Feb 2019

H-RT should be the standard of care for men with low risk prostate cancer, study shows

Results from the NRG Oncology clinical study NRG-RTOG 0415 determined that a hypofractionated radiotherapy schedule, a treatment schedule that delivers a total dose of radiotherapy over a shorter period of time, is not worse than the conventional radiotherapy schedule in terms of bowel, bladder, sexual, and general quality of life as well as anxiety and depression for men with low risk prostate cancer.

15 Feb 2019

Racial disparities in cancer deaths on the decline for America

A new report has concluded that the racial disparities between cancer deaths among white and black Americans is on the decline.

15 Feb 2019

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.

15 Feb 2019

Few primary care physicians lack enough knowledge of cancer treatment options

The idea of team-based cancer care most often focuses on involving primary care physicians in the care of cancer survivors. But research has shown patients are discussing initial cancer treatment options with their primary care doctors.

13 Feb 2019

Prostate News and Research

Prophylactic cranial irradiation used as standard approach for patients with NSCLC

Hormonal treatment associated with depression in men with prostate cancer

Study highlights the need for psychiatric care to be integrated into cancer treatment

Compounds found in coffee may inhibit growth of prostate cancer

Testosterone treatment lowers recurrence rates in low-risk prostate cancer patients

Prostate cancer treatment breakthrough

New risk model can predict survival of non-metastatic prostate cancer patients

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Cancer patients with mental health history have greater risk of death

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma

Miniature tumor organoids could help guide treatment decisions for people with rare cancers

New protein 'switch' could stop progression of blood-poisoning and increase chances of survival

Lack of diversity in cell lines does not allow minorities to reap the benefits of precision medicine

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

New AI can identify, predict development of different combinations of cancer symptoms

H-RT should be the standard of care for men with low risk prostate cancer, study shows

Racial disparities in cancer deaths on the decline for America

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Few primary care physicians lack enough knowledge of cancer treatment options

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News